<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of a woman who developed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> with <z:e sem="disease" ids="C0019087" disease_type="Disease or Syndrome" abbrv="">hemorrhagic diathesis</z:e> during adjuvant treatment of colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> with <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> and leucovorin </plain></SENT>
<SENT sid="1" pm="."><plain>A 55-year-old woman started adjuvant chemotherapy with <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> and leucovorin (mFOLFOX6) </plain></SENT>
<SENT sid="2" pm="."><plain>Prior to starting the 12th course of chemotherapy, a complete blood cell count showed the following values: neutrophils 1800/mm(3), platelets 136,000/m(3) and <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> 11.1 g/dl </plain></SENT>
<SENT sid="3" pm="."><plain>A blood count revealed that the platelet levels had dropped to 35,000/mm(3), with no significant changes in <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> levels following the course </plain></SENT>
<SENT sid="4" pm="."><plain>The administration of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> was begun and the platelet number was recovered </plain></SENT>
<SENT sid="5" pm="."><plain>Clinicians should be aware of the possibility of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>-induced hematological emergencies during the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients in order to optimize supportive treatment and avoid toxic mortality </plain></SENT>
</text></document>